tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Graham Perry, 2 are a BUY (100%).
Analyst Graham Perry, currently employed at BAML, carries an average stock price target met ratio of 100% that have a potential upside of 36.12% achieved within 636 days.
Graham Perry’s has documented 3 price targets and ratings displayed on 1 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on NVS, Novartis AG ADR at 11-Sep-2024.
Analyst best performing recommendations are on NVS (NOVARTIS AG ADR).
The best stock recommendation documented was for NVS (NOVARTIS AG ADR) at 10/4/2023. The price target of $118 was fulfilled within 636 days with a profit of $31.31 (36.12%) receiving and performance score of 0.57.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 26-Mar-2026
$170
$14.59 (9.39%)
Hold Since 11-Mar-2026
$180
$33.97 (23.26%)
$105
Sell Since 12-Sep-2025
$118
$-30.18 (-20.37%)
$121
What Year was the first public recommendation made by Graham Perry?
